Skip to main content
Journal ArticleOPEN ACCESS

HER2-positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab-based chemotherapy: A case report

Clinical Case Reports (2020) 8(12) 2878-2882
DOI: 10.1002/ccr3.3209
1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This case highlights the rare entity, salivary duct carcinoma (SDC), which is difficult to diagnose and manage. It is the first published case of a metastatic, HER2-positive parotid SDC successfully treated by a dual anti-HER2 treatment associated to a chemotherapy.

Author supplied keywords

Cite

CITATION STYLE

APA

Longo, R., Legros, P. O., Talbi, M., Wagner, M., Paraschiv, E. A., Campitiello, M., … Rozzi, A. (2020). HER2-positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab-based chemotherapy: A case report. Clinical Case Reports, 8(12), 2878–2882. https://doi.org/10.1002/ccr3.3209

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free